Read + Share
Amedeo Smart
Independent Medical Education
Zhang L, Zhang B, Wei M, Xu Z, et al. TRIM22 inhibits endometrial cancer progression through the NOD2/NFkappaB signaling pathway and confers a favorable prognosis. Int J Oncol 2020 Mar 4. doi: 10.3892/ijo.2020.5004.PMID: 32319602
Email
LinkedIn
Facebook
Twitter
Privacy Policy